ARL11 anticorps (Middle Region)
-
- Antigène Voir toutes ARL11 Anticorps
- ARL11 (ADP-Ribosylation Factor-Like 11 (ARL11))
-
Épitope
- Middle Region
-
Reactivité
- Humain, Rat, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ARL11 est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- ARL11 antibody was raised against the middle region of ARL11
- Purification
- Affinity purified
- Immunogène
- ARL11 antibody was raised using the middle region of ARL11 corresponding to a region with amino acids WKDYLEGTDILVYVLDSTDEARLPESAAELTEVLNDPNMAGVPFLVLANK
- Top Product
- Discover our top product ARL11 Anticorps primaire
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
ARL11 Blocking Peptide, catalog no. 33R-9959, is also available for use as a blocking control in assays to test for specificity of this ARL11 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ARL11 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- ARL11 (ADP-Ribosylation Factor-Like 11 (ARL11))
- Autre désignation
- ARL11 (ARL11 Produits)
- Synonymes
- anticorps zgc:56090, anticorps wu:fc38d01, anticorps arl11, anticorps MGC89886, anticorps ARL11, anticorps MGC154392, anticorps ARLTS1, anticorps C730007L20Rik, anticorps ADP-ribosylation factor-like 11, anticorps ADP ribosylation factor like GTPase 11, anticorps ADP-ribosylation factor like GTPase 11, anticorps arl11, anticorps ARL11, anticorps Arl11
- Sujet
- ARL11 belongs to the small GTPase superfamily, Arf family. It may play a role in apoptosis and act as a tumor suppressor. Defects in ARL11 may be a cause of susceptibility to chronic lymphocytic leukemia (CLL).
- Poids moléculaire
- 21 kDa (MW of target protein)
-